Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Muscarinic Acetylcholine Receptor market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Muscarinic Acetylcholine Receptor market segmented into
M1
M4
M5
Others
Based on the end-use, the global Muscarinic Acetylcholine Receptor market classified into
Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment
Based on geography, the global Muscarinic Acetylcholine Receptor market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Anavex Life Sciences Corp
AstraZeneca Plc
Heptares Therapeutics Ltd
Karuna Pharmaceuticals Inc
NeuroHealing Pharmaceuticals Inc
Sumitomo Dainippon Pharma Co Ltd
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MUSCARINIC ACETYLCHOLINE RECEPTOR INDUSTRY
2.1 Summary about Muscarinic Acetylcholine Receptor Industry
2.2 Muscarinic Acetylcholine Receptor Market Trends
2.2.1 Muscarinic Acetylcholine Receptor Production & Consumption Trends
2.2.2 Muscarinic Acetylcholine Receptor Demand Structure Trends
2.3 Muscarinic Acetylcholine Receptor Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 M1
4.2.2 M4
4.2.3 M5
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Attention Deficit Hyperactivity Disorder
4.3.2 Psychiatric Disorders
4.3.3 Alzheimer's Disease
4.3.4 Chronic Obstructive Pulmonary Disease
4.3.5 Memory Impairment
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 M1
5.2.2 M4
5.2.3 M5
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Attention Deficit Hyperactivity Disorder
5.3.2 Psychiatric Disorders
5.3.3 Alzheimer's Disease
5.3.4 Chronic Obstructive Pulmonary Disease
5.3.5 Memory Impairment
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 M1
6.2.2 M4
6.2.3 M5
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Attention Deficit Hyperactivity Disorder
6.3.2 Psychiatric Disorders
6.3.3 Alzheimer's Disease
6.3.4 Chronic Obstructive Pulmonary Disease
6.3.5 Memory Impairment
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 M1
7.2.2 M4
7.2.3 M5
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Attention Deficit Hyperactivity Disorder
7.3.2 Psychiatric Disorders
7.3.3 Alzheimer's Disease
7.3.4 Chronic Obstructive Pulmonary Disease
7.3.5 Memory Impairment
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 M1
8.2.2 M4
8.2.3 M5
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Attention Deficit Hyperactivity Disorder
8.3.2 Psychiatric Disorders
8.3.3 Alzheimer's Disease
8.3.4 Chronic Obstructive Pulmonary Disease
8.3.5 Memory Impairment
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 M1
9.2.2 M4
9.2.3 M5
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Attention Deficit Hyperactivity Disorder
9.3.2 Psychiatric Disorders
9.3.3 Alzheimer's Disease
9.3.4 Chronic Obstructive Pulmonary Disease
9.3.5 Memory Impairment
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Anavex Life Sciences Corp
10.1.2 AstraZeneca Plc
10.1.3 Heptares Therapeutics Ltd
10.1.4 Karuna Pharmaceuticals Inc
10.1.5 NeuroHealing Pharmaceuticals Inc
10.1.6 Sumitomo Dainippon Pharma Co Ltd
10.2 Muscarinic Acetylcholine Receptor Sales Date of Major Players (2017-2020e)
10.2.1 Anavex Life Sciences Corp
10.2.2 AstraZeneca Plc
10.2.3 Heptares Therapeutics Ltd
10.2.4 Karuna Pharmaceuticals Inc
10.2.5 NeuroHealing Pharmaceuticals Inc
10.2.6 Sumitomo Dainippon Pharma Co Ltd
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Muscarinic Acetylcholine Receptor Product Type Overview
Table Muscarinic Acetylcholine Receptor Product Type Market Share List
Table Muscarinic Acetylcholine Receptor Product Type of Major Players
Table Brief Introduction of Anavex Life Sciences Corp
Table Brief Introduction of AstraZeneca Plc
Table Brief Introduction of Heptares Therapeutics Ltd
Table Brief Introduction of Karuna Pharmaceuticals Inc
Table Brief Introduction of NeuroHealing Pharmaceuticals Inc
Table Brief Introduction of Sumitomo Dainippon Pharma Co Ltd
Table Products & Services of Anavex Life Sciences Corp
Table Products & Services of AstraZeneca Plc
Table Products & Services of Heptares Therapeutics Ltd
Table Products & Services of Karuna Pharmaceuticals Inc
Table Products & Services of NeuroHealing Pharmaceuticals Inc
Table Products & Services of Sumitomo Dainippon Pharma Co Ltd
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Muscarinic Acetylcholine Receptor Market Forecast (Million USD) by Region 2021f-2026f
Table Global Muscarinic Acetylcholine Receptor Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Muscarinic Acetylcholine Receptor Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Muscarinic Acetylcholine Receptor Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Muscarinic Acetylcholine Receptor Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Muscarinic Acetylcholine Receptor Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Muscarinic Acetylcholine Receptor Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Muscarinic Acetylcholine Receptor Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Muscarinic Acetylcholine Receptor Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Muscarinic Acetylcholine Receptor Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Muscarinic Acetylcholine Receptor Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Psychiatric Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Memory Impairment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Psychiatric Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Memory Impairment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Psychiatric Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Memory Impairment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Psychiatric Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Memory Impairment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Psychiatric Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Memory Impairment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M1 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Psychiatric Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Memory Impairment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Muscarinic Acetylcholine Receptor Sales Revenue (Million USD) of Anavex Life Sciences Corp 2017-2020e
Figure Muscarinic Acetylcholine Receptor Sales Revenue (Million USD) of AstraZeneca Plc 2017-2020e
Figure Muscarinic Acetylcholine Receptor Sales Revenue (Million USD) of Heptares Therapeutics Ltd 2017-2020e
Figure Muscarinic Acetylcholine Receptor Sales Revenue (Million USD) of Karuna Pharmaceuticals Inc 2017-2020e
Figure Muscarinic Acetylcholine Receptor Sales Revenue (Million USD) of NeuroHealing Pharmaceuticals Inc 2017-2020e
Figure Muscarinic Acetylcholine Receptor Sales Revenue (Million USD) of Sumitomo Dainippon Pharma Co Ltd 2017-2020e